DRB1104 and DQ Alleles: Expression of 21-Hydroxylase Autoantibodies and Risk of Progression to Addisons Disease,1
Liping Yu,
Karl W. Brewer,
Sherman Gates,
Anya Wu,
Tianbao Wang,
Sunanda R. Babu,
Peter A. Gottlieb,
Brian M. Freed,
Janelle Noble,
Henry A. Erlich,
Marian J. Rewers and
George S. Eisenbarth
Barbara Davis Center for Childhood Diabetes (L.Y., K.W.B., T.W.,
S.R.B., P.A.G., M.J.R., G.S.E.) and Clinical Immunology and
Histocompatibility Laboratory (B.M.F.), University of Colorado, Denver,
Colorado 80262; Stratton Veterans Affairs Medical Center (S.G., A.W.),
Albany, New York 12208; and Roche Molecular Systems (H.A.E.),
Alameda, California 95401
Address all correspondence and requests for reprints to: George S. Eisenbarth, M.D., Ph.D., Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Box B140, Denver, Colorado 80262. E-mail:
george.eisenbarth{at}uchsc.edu
Of 957 patients with type 1 diabetes without known Addisonsdisease
1.6% (n = 15) were positive for 21-hydroxylase autoantibodies.
AmongDQ8/DQ2 heterozygous patients, the percentage expressing
21-hydroxylaseautoantibodies was 5% (10 of 208) vs.
less than 0.5% of patientswith neither DQ8 nor DQ2. Three of the
diabet-ic patients foundto have 21-hydroxylase autoantibodies on
screen-ing were subsequentlydiagnosed with Addisons disease.
Overall, the genotypeDQ8/DQ2, consisting of DRB1*0404/DQ8
with DRB1*0301/DQ2, waspresent in 14 of 21 patients with Addisons
disease (8of 12 with diabetes and 6 of 9 without diabetes or antiislet
autoantibodies)vs. 0.7% of the general population (109
of 15,547; P < 10-6)and 11% of
patients with DM without Addisons disease(62 of 578;
P < 10-6). Among patients with
diabetes withDQ8, Addisons disease was strongly associated with the
specificDRB1 subtype, DRB1*0404 (8 of 9 patients from 8 families, in
contrastto only 109 of 408 DQ8 DM patients with diabetes without
Addisonsdisease having DRB1*0404; P < 0.001).
Among 21-hydroxylaseautoantibody-positive DQ8 patients, 80% with
DRB1*0404 (12 of15) had Addisons disease, in contrast to 1 of 10
autoantibody-positivepatients with DRB1*0401 or DRB1*0402
(P < 0.001). We concludethat patients with
DRB1*0404 and 21-hydroxylase autoantibodiesare at high risk for
Addisons disease. Patients withDRB1*0401 and DRB1*0402 have more
limited progression to Addisonsdisease despite the presence of
21-hydroxylase autoantibodies.
This article has been cited by other articles:
A. Brozzetti, S. Marzotti, C. Tortoioli, V. Bini, R. Giordano, F. Dotta, C. Betterle, A. De Bellis, G. Arnaldi, V. Toscano, et al. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies
Eur. J. Endocrinol.,
February 1, 2010;
162(2):
361 - 369.
[Abstract][Full Text][PDF]
M. M. Erichsen, K. Lovas, B. Skinningsrud, A. B. Wolff, D. E. Undlien, J. Svartberg, K. J. Fougner, T. J. Berg, J. Bollerslev, B. Mella, et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry
J. Clin. Endocrinol. Metab.,
December 1, 2009;
94(12):
4882 - 4890.
[Abstract][Full Text][PDF]
E. Bratland, B. Skinningsrud, D. E. Undlien, E. Mozes, and E. S. Husebye T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency
J. Clin. Endocrinol. Metab.,
December 1, 2009;
94(12):
5117 - 5124.
[Abstract][Full Text][PDF]
T. M. Triolo, E. E. Baschal, T. K. Armstrong, C. S. Toews, P. R. Fain, M. J. Rewers, L. Yu, D. Miao, G. S. Eisenbarth, P. A. Gottlieb, et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
November 1, 2009;
94(11):
4517 - 4523.
[Abstract][Full Text][PDF]
I. Gavanescu, C. Benoist, and D. Mathis B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: A therapeutic approach for APECED patients
PNAS,
September 2, 2008;
105(35):
13009 - 13014.
[Abstract][Full Text][PDF]
Z Gombos, R Hermann, M Kiviniemi, S Nejentsev, K Reimand, V Fadeyev, P Peterson, R Uibo, and J Ilonen Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations
Eur. J. Endocrinol.,
December 1, 2007;
157(6):
757 - 761.
[Abstract][Full Text][PDF]
G. Coco, C. Dal Pra, F. Presotto, M. P. Albergoni, C. Canova, B. Pedini, R. Zanchetta, S. Chen, J. Furmaniak, B. Rees Smith, et al. Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1637 - 1645.
[Abstract][Full Text][PDF]
J. M. Barker Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1210 - 1217.
[Abstract][Full Text][PDF]
H. Kahles, E. Ramos-Lopez, B. Lange, O. Zwermann, M. Reincke, and K. Badenhoop Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population
Eur. J. Endocrinol.,
December 1, 2005;
153(6):
895 - 899.
[Abstract][Full Text][PDF]
J. M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J. C. Nelson, P. A. Gottlieb, M. Rewers, et al. Autoantibody "Subspecificity" in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups
Diabetes Care,
April 1, 2005;
28(4):
850 - 855.
[Abstract][Full Text][PDF]
G. Gambelunghe, I. Kockum, V. Bini, G. D. Giorgi, F. Celi, C. Betterle, R. Giordano, R. Libe, A. Falorni, and on behalf of the Umbria Type 1 Diabetes Registry a Retrovirus-Like Long-Terminal Repeat DQ-LTR13 and Genetic Susceptibility to Type 1 Diabetes and Autoimmune Addison's Disease
Diabetes,
March 1, 2005;
54(3):
900 - 905.
[Abstract][Full Text][PDF]
J. M. Barker, A. Ide, C. Hostetler, L. Yu, D. Miao, P. R. Fain, G. S. Eisenbarth, and P. A. Gottlieb Endocrine and Immunogenetic Testing in Individuals with Type 1 Diabetes and 21-Hydroxylase Autoantibodies: Addison's Disease in a High-Risk Population
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
128 - 134.
[Abstract][Full Text][PDF]
G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes
N. Engl. J. Med.,
May 13, 2004;
350(20):
2068 - 2079.
[Full Text][PDF]
S. D. Marks, R. Girgis, and R. M. Couch Screening for Adrenal Antibodies in Children With Type 1 Diabetes and Autoimmune Thyroid Disease
Diabetes Care,
November 1, 2003;
26(11):
3187 - 3188.
[Full Text][PDF]
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction
Endocr. Rev.,
June 1, 2002;
23(3):
327 - 364.
[Abstract][Full Text][PDF]
V. Kumar, M. Rajadhyaksha, and J. Wortsman Celiac Disease-Associated Autoimmune Endocrinopathies
Clin. Vaccine Immunol.,
July 1, 2001;
8(4):
678 - 685.
[Abstract][Full Text][PDF]
C. Jaeger, E. Hatziagelaki, R. Petzoldt, and R. G. Bretzel Comparative Analysis of Organ-Specific Autoantibodies and Celiac Disease--Associated Antibodies in Type 1 Diabetic Patients, Their First-Degree Relatives, and Healthy Control Subjects
Diabetes Care,
January 1, 2001;
24(1):
27 - 32.
[Abstract][Full Text]
B. Vaidya, H. Imrie, D. R. Geatch, P. Perros, S. G. Ball, P. H. Baylis, D. Carr, S. J. Hurel, R. A. James, W. F. Kelly, et al. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison's Disease
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
688 - 691.
[Abstract][Full Text]
G. Gambelunghe, A. Falorni, M. Ghaderi, S. Laureti, C. Tortoioli, F. Santeusanio, P. Brunetti, and C. B. Sanjeevi Microsatellite Polymorphism of the MHC Class I Chain-Related (MIC-A and MIC-B) Genes Marks the Risk for Autoimmune Addison's Disease
J. Clin. Endocrinol. Metab.,
October 1, 1999;
84(10):
3701 - 3707.
[Abstract][Full Text][PDF]